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THE NURSES ROLE IN ASSESSING ENDOCRINE DYSFUNCTION AND UN-
DERSTANDING PARAMETERS OF METABOLIC SYNDROME FOLLOWING
HEMATOPOETIC STEM CELL TRANSPLANT
Garee, A.M., Skeens,M.A., Bajwa, R., Termuhlen, A. Nationwide Child-
ren’s Hospital, Columbus, OH
The increase use of HSCT in the treatment of hematologic, im-
munologic, genetic and nonhematological diseases in recent years
has put patients at an increased risk of multiple endocrine organ dys-
functions as a result of the chemo-radiotherapy conditioning. Hypo-
thyroidism, hypopituitarism, and hypogonadism all contribute to
growth failure and delayed or absent puberty in this group of pa-
tients. There is also an increased incidence of metabolic syndrome
(MS) after HSCT in pediatric and adults.
Metabolic syndrome is defined as visceral obesity, glucose intoler-
ance, arterial hypertension and dyslipidemia. Insulin resistance and
endothelial dysfunction are the primary events of metabolic
syndrome. Cardiovascular risk factors and comorbidities are listed
in Table 1.Cardiovascular Risk
Factors/
ComorbiditiesFasting lipid profile; Smoking History; Family
history of early CVD first degree pedigree
(M<55; F<65); Blood pressure (3 occasions)
interpreted for age/sex/height; BMI; Fasting
glucose; physical activityThe nurse’s essential roles include assessment and education related
to lifestyle changes. Key assessment skills in metabolic syndrome
consist of tanner staging, abdominal girth, as well as hip to waist ra-
tio. Identification of subtle changes of the individual components
may allow for early intervention and risk factor modification therapy
that could reduce the risk of morbidity and mortality. Treatment
goals include; BMI\95th percentile for sex/age, BP\95th percen-
tile for age/sex/height, LDL cholesterol\160mg/dl, FG\100mg/
dL; HbA1c\ 7%. Nurses play a crucial role in educating patients
related to therapeutic lifestyle changes. Decreasing total fat and cal-
orie intake, encouraging daily activity, nutrition education and phar-
macologic management as needed are areas nurses can significantly
impact. Drug therapy in these patients should only be considered
if lifestyle changes are unsuccessful.
As the number of long term childhood HSCT survivors grows, so
does the risk for long term sequela including metabolic syndrome.
The nurse’s role in caring, assessing, educating and providing treat-
ment for these patients is pivotal in overall outcomes of the disease.621
INFERTILITY, REPRODUCTIVE FUNCTION AND THE PEDIATRIC HEMATO-
POIETIC STEM CELL TRANSPLANT PATIENT: TOWARDS A BETTER
UNDERSTANDING
Skeens, M.A.1, Garee, A.1, Gracia, C.2 1Nationwide Children’s Hospital,
Columbus, OH; 2PENN, Philadelphia, PA
Infertility is one of the most common chronic medical problems
reported by childhood cancer survivors. Loss of fertility is identified
as the most important concern after mortality by newly diagnosed
cancer patients. The widespread use of HSCT has led to a growing
number of long term survivors and late effects, including infertility
and premature ovarian failure (POF). Risk factors are listed in table 1.
Table 1. Risk FactorsRisk Factors High dose alkylating agents; TBI; Prolonged graft
vs. host disease; older female age at time of
transplantPOF in childhood can result in lack of pubertal development and in-
fertility. The two forms of POF are; acute ovarian failure (AOF) and
premature menopause. AOF occurs in patients with amenorrhea
during chemotherapy or shortly after completion. Premature meno-
pause occurs when patients retain ovarian function, then experience
menopause at \ 40 years of age. This leads to early loss ofreproductive potential and cessation of ovarian sex hormone produc-
tion. Prematuremenopause causes an increased risk for osteoporosis,
cardiovascular dysfunction and psychosexual dysfunction.
Historically, follicle stimulating hormone (FSH) and amenorrhea
have been utilized as markers for ovarian failure. Despite these crite-
ria, it has been well documented that pregnancies in childhood can-
cer survivors occur. Therefore, FSH levels or menstruation do not
appear indicative of fertility. Recently, anti-Mullerian hormone
(AMH) has been identified as a marker for ovarian reserve. Previous
clinical studies have shown the number of antral follicles and age cor-
relates with serum AMH levels. Low levels of AMH are correlated
with infertility. Serum AMH levels seem to be related to the onset
of menopause and a marker for ovarian ageing. AMH has been de-
scribed as a useful marker of ovarian reserve in adult survivors of can-
cer diagnosis but limited data exists in the pediatric population.
Data related to infertility and ovarian failure in pediatric HSCT
patients is limited. Further research examining the impact of POF
and premature menopause, as well as the role of AMH is
imperative.622
THE NURSING IMPACT ON CARE OF SIBLING DONORS IN PEDIATRIC
STEM CELL TRANSPLANTATION
Skeens, M.A., Garee, A., Taylor, G., Laudick, M., Termuhlen, A.
Nationwide Children’s Hopital, Columbus, OH
Awareness and understanding of the new guidelines from the
American Academy of Pediatrics (AAP) regarding children who are
potential hematopoietic stem cell donors will enable nurses involved
in the care of the pediatric bone marrow transplant patients to better
support and advocate for the sibling donor, recipient, and families as
they navigate the bone marrow transplant process. Reduced risk of
transplant complications when compared to unrelated donors makes
matched siblings the favorable choice. Children are donors for 75%
of pediatric transplants (Packman, Gong, VanZutphen, Shaffer, &
Crittenden, 2004). The potential risks of donating bone marrow
are listed in Table 1.
Table 1. Sibling Donor RisksMajor/Serious Risks Anesthesia Nerve, bone or
tissue injuryMorbidity Risks Blood loss Wound
Infection
Pain at aspiration
siteShort-term adverse
effectsFatigue Pain (site, low
back pain)
Headaches InsomniaLong-term adverse
effectsChronic
pain (rare)Psychosocial risks Distress Inadequately
prepared
Post traumatic
stress
Anxiety Low self
esteemThere is no direct medical benefit from acting as a HSC donor.
There may be both significant psychosocial benefit or risk. In weigh-
ing the risks and benefits, the American Academy of Pediatrics re-
cently stated that minors can ethically participate as HSC donors if
5 criteria are met. The 5 criteria include: (1) no available compatible
adult donor, (2) strong positive relationship between donor and re-
cipient, (3) likely recipient benefit, (4) donor risks are minimized,
and (5) parental permission and donor assent (if appropriate) are
obtained. In addition, the AAP recommends an independent donor
advocate for all siblings and families. This advocate is responsible
for protecting the well-being of the donor. The pediatric bone mar-
row transplant nurse can integrate the addition of the donor advocate
into the BMT process, aid in family, patient, and donor education,
and increase the awareness of potential long term complications of
sibling donation. The nurse can be a resource to the family and to
the medical staff in identifying opportunities for donor intervention
as the patient undergoes transplantation and follow-up. Nurses are
ideal to conduct future research to improve understanding of the
medical and psychological needs of sibling donors.
